Methyl iodide → 5-(S)-Azidomethyl-3-[4'-methylthio-3'-fluorophenyl]oxazolidine-2-one
反応式
C(O)(C(F)(F)F)=O.C([SiH](C(C)C)C(C)C)(C)C.[N:18]([CH2:21][C@H:22]1[O:26][C:25](=[O:27])[N:24]([C:28]2[CH:33]=[CH:32][C:31]([S:34][C:35](C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)=[C:30]([F:54])[CH:29]=2)[CH2:23]1)=[N+:19]=[N-:20].IC.C(N(CC)CC)C>C(Cl)Cl>[N:18]([CH2:21][C@H:22]1[O:26][C:25](=[O:27])[N:24]([C:28]2[CH:33]=[CH:32][C:31]([S:34][CH3:35])=[C:30]([F:54])[CH:29]=2)[CH2:23]1)=[N+:19]=[N-:20]参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
5% TFA and 2.5% triisopropylsilane in DCM (4 ml) was added to 5-(S)-azidomethyl-3-[4′-triphenylmethylthio-3′-fluorophenyl]oxazolidine-2-one (0.250 g, 0.490 mmol; prepared as described above for Example 6), and the mixture stirred for 1 h at r.t. Solvent was removed under vacuum and the residue dissolved in DMF (2 ml). Iodomethane (0.046 ml, 0.735 mmol) was added followed by dropwise addition of triethylamine (0.136 ml, 0.979 mmol). The mixture was stirred at r.t. for 2 h, evaporated, and the residue purified by PTLC (50% ethyl acetate in DCM) to give the product as a white solid (0.124 g, 90%). MS (m/z): [M+H]+=283.
後処理
- customSolvent was removed under vacuum
- dissolutionthe residue dissolved in DMF (2 ml)
- stirringThe mixture was stirred at r.t. for 2 h
- customevaporated
- customthe residue purified by PTLC (50% ethyl acetate in DCM)
出典と根拠
- ORDレコード
- ord-33402d1c398247ebb8f744b85390b18d
- 出典データセット
- uspto-grants-2004_06
- 特許番号
- US06743811B2
反応ノート
読み込み中…